ERO:PA:PA-SPDR MSCI Europe UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 338.512

Change

+1.78 (+0.53)%

Market Cap

USD 0.29B

Volume

236.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.22 (-0.46%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-0.70 (-0.12%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.21 (+0.05%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.04 (+0.10%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.54 (+0.60%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

N/A

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.43 (+0.12%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-0.06 (-0.10%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.22 (+0.14%)

USD 5.17B

ETFs Containing ERO:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.78% 84% B 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.78% 84% B 76% C+
Trailing 12 Months  
Capital Gain 15.13% 58% F 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.13% 57% F 68% D+
Trailing 5 Years  
Capital Gain 48.20% 64% D 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 48.20% 62% D 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 12.56% 69% C- 70% C-
Dividend Return 12.56% 67% D+ 34% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.26% 54% F 41% F
Risk Adjusted Return 102.47% 82% B 46% F
Market Capitalization 0.29B 54% F 61% D-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike